In vitro assessment of archaeosome stability for developing oral delivery systems

International Journal of Pharmaceutics

Volumn 194, Issue 1, 2000, Pages 39-49

  Patel, Girishchandra B ^a   Agnew, Brian J ^a   Deschatelets, Lise ^a   Fleming, L Perry ^a   Sprott, G Dennis ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Archaeal lipid liposomes; Archaeosomes; GI tract; Oral delivery system; Stability

Indexed keywords

LIPOSOME;

ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; HUMAN; METHANOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; THERMODYNAMICS;

ADMINISTRATION, ORAL; ARCHAEA; BILE; CARBON RADIOISOTOPES; DIGESTIVE SYSTEM; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; LIPASE; LIPID METABOLISM; LIPIDS; LIPOSOMES; METHANOBACTERIUM; METHANOSARCINA; PANCREAS; SERUM ALBUMIN, BOVINE; SUCROSE; THERMOPLASMA;

EID: 0033992169     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00331-2     Document Type: Article

References (37)

1. Aramaki Y., Tomizawa H., Hara T., Yachi K., Kikuchi H., Tsuchiya S. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm. Res. 10:1993;1228-1231.
2. Ausborn M., Nuhn P., Schreier H. Stabilization of liposomes by freeze-thaw- and lyophilization techniques: problems and opportunities. Eur. J. Pharm. Biopharm. 38:1992;133-139.
3. Beveridge T.J., Choquet C.G., Patel G.B., Sprott G.D. Freeze-fracture planes of methanogen membranes correlate with the content of tetraether lipids. J. Bacteriol. 175:1993;1191-1197.
4. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
5. Bonté F., Hsu M.J., Papp A., Wu K., Regen S.L., Juliano R.L. Interactions of polymerizable phosphatidylcholine vesicles with blood components: relevance to biocompatibility. Biochim. Biophys. Acta. 900:1987;1-9.
6. Chen H., Torchilin V., Langer R. Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability. J. Controlled Release. 42:1996;263-272.
7. Chiang C.-M., Weiner N. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies. Int. J. Pharm. 37:1987;75-85.
8. Choquet C.G., Patel G.B., Beveridge T.J., Sprott G.D. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Appl. Microbiol. Biotechnol. 42:1994;375-384.
9. Couvreur P., Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Delivery Rev. 10:1993;141-162.
10. Freisleben H.-J., Bormann J., Litzinger D.C., Lehr F., Rudolph P., Schatton W., Huang L. Toxicity and biodistribution of liposomes of the main phospholipid from the archaeobacterium Thermoplasma acidophilum in mice. J. Liposome Res. 5:1995;215-223.
11. Freisleben H.-J., Neisser C., Hartmann M., Rudolph P., Geck P., Ring K., Müller E.G. Influence of the main phospholipid (MPL) from Thermoplasma acidophilum and of liposomes from MPL on living cells: cytotoxicity and mutagenicity. J. Liposome Res. 3:1993;817-833.
12. Han M., Watarai S., Kobayashi K., Yasuda T. Application of liposomes for development of oral vaccines; study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. J. Vet. Med. Sci. 59:1997;1109-1114.
13. Iwanaga K., Ono S., Narioka K., Morimmoto K., Kakemi M., Yamashita S., Nango M., Oku N. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int. J. Pharm. 157:1997;73-80.
14. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16:1995;351-380.
15. Kates M. Archaebacterial lipids: structure, biosynthesis and function. Biochem. Soc. Symp. 58:1993;51-72.
16. 2 from human duodenal juice. Biochim. Biophys. Acta. 1002:1989;395-397.
17. Lasic D.D. Novel application of liposomes. Trends Biotechnol. 16:1998;307-321.
18. Lo S.-L., Chang E.L. Purification and characterization of a liposomal-forming tetraether lipid fraction. Biochem. Biophys. Res Commun. 167:1990;238-243.
19. Makabi-Panzu B., Sprott G.D., Patel G.B. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein. Vaccine. 16:1998;1504-1510.
20. Nagata M., Yotsuyanagi T., Ikeda K. A two-step model of disintegration kinetics of liposomes in bile salts. Chem. Pharm. Bull. 36:1988;1508-1513.
21. New R.R.C. Characterization of liposomes. New R.R.C. Liposomes: A Practical Approach. 1990;105-161 IRL Press at Oxford University Press, Oxford, UK.
22. O'Connor C.J., Wallace R.G., Iwamoto K., Taguchi T., Sunamoto J. Bile salt damage of egg phosphatidylcholine liposomes. Biochim. Biophys. Acta. 817:1985;95-102.
23. O'Hagan D.T. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations. Clin. Pharmacokinet. 22:1992;1-10.
24. Okada J., Cohen S., Langer R. In vitro evaluation of polymerized liposomes as an oral drug delivery system. Pharm. Res. 12:1995;576-582.
25. Patel G.B., Agnew B.J., Jarrell H.C., Sprott G.D. Stability of liposomes prepared from the total polar lipids of Methanosarcina mazei is affected by the specific salt form of the lipids. J. Liposome Res. 9:1999;229-245.
26. Ravily V., Santaella C., Vierling P. Membrane permeability and stability in buffer and in human serum of fluorinated di-O-alkylglycerophosphocholine-based liposomes. Biochim. Biophys. Acta. 1285:1996;79-90.
27. Richards M.H., Gardner C.R. Effects of bile salts on the structural integrity of liposomes. Biochim. Biophys. Acta. 543:1978;508-522.
28. Reilly R.M., Domingo R., Sandhu J. Oral delivery of antibodies. Future pharmacokinetic trends. Clin. Pharmacokinet. 32:1997;313-323.
29. Rogers J.A., Anderson K.E. The potential of liposomes in oral drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;421-480.
30. Rowland R.N., Woodley J.F. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta. 620:1980;400-409.
31. Senior J.H. Fate and behaviour of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
32. Sprott G.D. Structures of archaebacterial membrane lipids. J. Bioenerget. Biomembr. 24:1992;555-566.
33. Sprott G.D., Choquet C.G., Patel G.B. Purification of ether lipids and liposome formation from polar lipid extracts of methanogenic Archaea. Sowers K.R. et al. Methanogens. Archaea - A Laboratory Manual. 1995;329-340 Cold Spring Harbor Laboratory Press, Plainview, NY.
34. Sprott G.D., Dicaire C.J., Fleming L.P., Patel G.B. Stability of liposomes prepared from archaeobacterial lipids and phosphatidylcholine mixtures. Cells Mater. 6:1996;143-155.
35. Sprott G.D., Tolson D.L., Patel G.B. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 154:1997;17-22.
36. Tolson D.L., Latta R.K., Patel G.B., Sprott G.D. Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells. J. Liposome Res. 64:1996;755-776.
37. Woodley J.F. Liposomes for oral administration of drugs. CRC Crit. Rev. Ther. Drug Carrier Syst. 2:1984;2-18.